Skip to main content

UBS Group AG

Position in ORGO — Organogenesis Holdings Inc.

CIK 1610520 ZURICH, V8

Position in ORGO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$871,659
+$379,819 QoQ
Shares Held
358,708
+72.8% QoQ
Ownership
0.279%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 135 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in ORGO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. ORGO ranks #43 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ORGO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $871,659 358,708
2026-03-31 $491,840 207,528
2025-12-31 $686,908 132,608
2025-09-30 $2,081,792 493,316
2025-06-30 $1,827,697 499,371
2025-03-31 $1,493,241 345,658
2024-12-31 $182,067 56,896
2024-09-30 $168,279 58,839
2024-06-30 $131,716 47,042
2024-03-31 $215,696 75,950
2023-12-31 $304,038 74,337
2023-09-30 $152,788 48,047
2023-06-30 $6,643 2,001
2023-03-31 $23,715 11,134
2022-12-31 $16,131 5,997
2022-09-30 $3 1
2022-06-30 $4 1
2022-03-31 $7 1
2021-12-31 $5,451 590
2021-09-30 $2,559,041 179,708
2021-06-30 $2,331,868 140,305
2021-03-31 $42,215 2,317
2020-12-31 $41,580 5,522
2020-09-30 $4,392 1,144
2020-06-30 $35,146 9,153
2020-03-31 $21,786 6,745